Arthritis News and Research

Latest Arthritis News and Research

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of The Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology.

18 Jun 2011

NASDAQ halts Regeneron's common stock

Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.

17 Jun 2011

HHS announces funding opportunity for national networks of community-based organizations

The U.S. Department of Health and Human Services (HHS) today announced a funding opportunity for national networks of community-based organizations to apply for more than $4 million in cooperative agreements.

17 Jun 2011

Positive results from etanercept pilot study against dermatomyositis

A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy.

17 Jun 2011

$Economic burden of fractures in Europe has been vastly underestimated: New report$

Economic burden of fractures in Europe has been vastly underestimated: New report

A new report launched today by the International Osteoporosis Foundation (IOF) in collaboration with the European Federation of Pharmaceutical Industry Associations (EFPIA) reveals that the burden of fractures in Europe has been vastly underestimated.

16 Jun 2011

Magnesium essential for absorption and metabolism of vitamin D and calcium

Magnesium deficiency is an important factor in the results obtained from vitamin D. According to Dr. Carolyn Dean, MD, ND, magnesium expert and Medical Director of the nonprofit Nutritional Magnesium Association, the effectiveness and benefits of vitamin D are greatly undermined in the absence of adequate levels of magnesium in the body.

15 Jun 2011

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.

15 Jun 2011

Research reveals how humans of different ancestry process polyunsaturated fat

Over the past decade, much progress has been made regarding the understanding and promise of personalized medicine. Scientists are just beginning to consider the impact of gene-diet interactions in different populations in regards to disease prevention and treatment.

15 Jun 2011

Humira defect lawyers file suit against Abbott Laboratories in federal court

Humira defect lawyers filed a lawsuit against Abbott Laboratories in federal court today claiming Abbott's blockbuster drug, Humira, caused a fungal infection resulting in the near-death of a Tennessee man.

14 Jun 2011

Nose spray vaccine for type 1 diabetes could be a reality soon

Melbourne researchers are nearing the development of a vaccine for type 1 diabetes, after showing that a nasal spray can stop the body's immune system from attacking insulin-producing cells.

13 Jun 2011

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, at the National Institute of Oncology in Budapest, Hungary. Enrollment is expected to start soon in this center. The study is already ongoing at twelve clinical sites in the United States, Canada, Poland and India.

13 Jun 2011

Scientists identify potential target for reversing deadly blood infection sepsis

By digging a little deeper, researchers may have found a potential target for reversing the deadly blood infection sepsis.

13 Jun 2011

Hanwha, Merck partner to develop and commercialize HD203

Merck, known as MSD outside the United States and Canada, and Hanwha Chemical Corporation today announced that they have entered into an exclusive global agreement to develop and commercialize a candidate biosimilar form of Enbrel.

13 Jun 2011

HSS to host international Osteoarthritis Summit on June 17, 18

Osteoarthritis (OA) is one of the most pressing health care challenges of our time, affecting 27 million Americans. In an effort to elucidate the latest information in diagnosis, treatment, research and prevention, Hospital for Special Surgery (HSS) will host an international Osteoarthritis Summit on June 17 and June 18.

13 Jun 2011

NYU Langone webinar discusses advances in the treatment of RA

Steven Abramson, MD, professor of medicine and director of the rheumatology division at NYU Langone Medical Center, hosted a webinar with colleagues from the medical center for rheumatoid arthritis community bloggers - bringing together, bench, bedside and the blogosphere to discuss advances in the investigation, care, and treatment of RA.

13 Jun 2011

HHS adds eight substances to 12th Report on Carcinogens

The U.S. Department of Health and Human Services added eight substances to its Report on Carcinogens, a science-based document that identifies chemicals and biological agents that may put people at increased risk for cancer.

13 Jun 2011

Poplar bud extracts can serve as good source of antioxidants for skin creams

Antioxidants are popular anti-aging ingredients in skin creams, and now scientists are reporting a new source of these healthful substances - leaf buds of poplar trees. Their study appears in the ACS' Journal of Agricultural and Food Chemistry.

9 Jun 2011

State roundup: N.J. plan would cut Medicaid by $500 million

States and territories are eligible for up to $40 million to strengthen and coordinate efforts to prevent chronic disease, the Health and Human Services Department announced Tuesday. The initiative is funded by the healthcare reform law and targets the nation's five leading chronic diseases: heart disease, cancer, stroke, diabetes and arthritis.

9 Jun 2011

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.

8 Jun 2011

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results from its randomised, double-blind, placebo-controlled Phase IIb clinical trial COMPONENT in RA.

8 Jun 2011

Arthritis News and Research

Latest Arthritis News and Research

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

NASDAQ halts Regeneron's common stock

HHS announces funding opportunity for national networks of community-based organizations

Positive results from etanercept pilot study against dermatomyositis

Economic burden of fractures in Europe has been vastly underestimated: New report

Magnesium essential for absorption and metabolism of vitamin D and calcium

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Research reveals how humans of different ancestry process polyunsaturated fat

Humira defect lawyers file suit against Abbott Laboratories in federal court

Nose spray vaccine for type 1 diabetes could be a reality soon

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

Scientists identify potential target for reversing deadly blood infection sepsis

Hanwha, Merck partner to develop and commercialize HD203

HSS to host international Osteoarthritis Summit on June 17, 18

NYU Langone webinar discusses advances in the treatment of RA

HHS adds eight substances to 12th Report on Carcinogens

Poplar bud extracts can serve as good source of antioxidants for skin creams

State roundup: N.J. plan would cut Medicaid by $500 million

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Arthritis News and Research

Latest Arthritis News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in